Iruxol mono (collagenase) · CNK 1677848

Product information

Iruxol mono
30 g
collagenase
1677848
7.75 / 10
Locked

Product properties

9001-12-1
D03BA52
Smith & Nephew
Ointment
BE160982
05000223453565
M1
Public
160982-01

Pharmacist Assessment

Normally available

This product has good current availability (score 7.75/10) and is historically stable (score 🔒/10). No action required.

Note: commercialization of this product will be stopped on 30/09/2026.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 17 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Planned
From 30/09/2026

Other reason

Adaptation of the treatment is possible
Available Active
Until 29/09/2026

Composition

2 ingredients

Substance Type Strength CAS
Active ingredient
0.24 {unit}
Active ingredient
1.2 {unit}

Additional information

Availability statistics

Available
0 days
2
0